Breast cancer drug trial halted early: what happened?
NCT ID NCT03535506
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This study looked at whether giving the drug palbociclib before surgery could help people with a very early form of breast cancer called DCIS. The plan was to enroll 24 people, but the study was stopped early with only 17 participants. The main goal was to see if it was even possible to run this type of study, not to prove the drug worked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DCIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Medstar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Conditions
Explore the condition pages connected to this study.